158 related articles for article (PubMed ID: 9755419)
1. New approaches to achieving human fertilization: a résumé.
Edwards RG
Hum Reprod; 1998 Jun; 13 Suppl 3():127-36; discussion 145-7. PubMed ID: 9755419
[No Abstract] [Full Text] [Related]
2. Predicting live birth outcomes after in vitro fertilisation.
Nelson SM; Lawlor DA
BJOG; 2012 Dec; 119(13):1668; author reply 1668-9. PubMed ID: 23164114
[No Abstract] [Full Text] [Related]
3. [Recommendations of good practice: medicines that induce ovulation (June 2003)].
AFSSAPS
Gynecol Obstet Fertil; 2003; 31(7-8):676-86. PubMed ID: 14563614
[No Abstract] [Full Text] [Related]
4. [Medically assisted procreation. Main biological, medical and ethical aspects ].
Roux C; Berdin A; Amiot C
Rev Prat; 2014 Dec; 64(10):1435-44. PubMed ID: 25665331
[No Abstract] [Full Text] [Related]
5. Ultrashort flare gonadotropin-releasing hormone (GnRH) agonist/GnRH antagonist protocol: a valuable tool in the armamentarium of ovulation induction for in vitro fertilization.
Orvieto R; Laufer N
Fertil Steril; 2014 Nov; 102(5):1254-5. PubMed ID: 25282471
[No Abstract] [Full Text] [Related]
6. Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose.
Ponzano A; Colangelo EC; Di Biase L; Romani F; Tiboni GM
Gynecol Endocrinol; 2017 Mar; 33(3):208-211. PubMed ID: 27922279
[TBL] [Abstract][Full Text] [Related]
7. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
[TBL] [Abstract][Full Text] [Related]
8. In vitro fertilization and embryo-transfer: the Monash group experiences 1981-83.
Leeton J; Trounson A; Wood C; Gianaroli L
Acta Eur Fertil; 1983; 14(2):95-100. PubMed ID: 6670440
[No Abstract] [Full Text] [Related]
9. Evaluation and treatment of the poor responder.
Schoolcraft WB
Clin Obstet Gynecol; 2006 Mar; 49(1):23-33. PubMed ID: 16456340
[No Abstract] [Full Text] [Related]
10. Repeated in vitro fertilization cycle attempts in patients undergoing controlled ovarian hyperstimulation with use of gonadotropin-releasing hormone antagonists.
Rabinson J; Ashkenazi J; Homburg R; Meltcer S; Anteby EY; Orvieto R
Fertil Steril; 2009 Apr; 91(4 Suppl):1473-5. PubMed ID: 18937940
[TBL] [Abstract][Full Text] [Related]
11. Assisted conception. I--General principles.
Rowell P; Braude P
BMJ; 2003 Oct; 327(7418):799-801. PubMed ID: 14525882
[No Abstract] [Full Text] [Related]
12. Predictive value of poor ovarian response to initial gonadotropin stimulation.
Keay SD; Jenkins JM
Fertil Steril; 2005 Dec; 84(6):1797; author reply 1797-8. PubMed ID: 16359996
[No Abstract] [Full Text] [Related]
13. Reproductive biology. Fertilization without sperm.
Aitken RJ; Irvine DS
Nature; 1996 Feb; 379(6565):493, 495. PubMed ID: 8596625
[No Abstract] [Full Text] [Related]
14. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
15. Ovulation induction in the era of recombinant gonadotropins and GnRH analogues.
Insler V; Lunenfeld B
Isr J Med Sci; 1996 Feb; 32(2):79-89. PubMed ID: 8631655
[No Abstract] [Full Text] [Related]
16. Pregnancy after endometrial scratching in infertile couples undergoing ovulation induction and intrauterine insemination cycles-a randomized controlled trial.
Goel T; Mahey R; Bhatla N; Kalaivani M; Pant S; Kriplani A
J Assist Reprod Genet; 2017 Aug; 34(8):1051-1058. PubMed ID: 28551840
[TBL] [Abstract][Full Text] [Related]
17. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
18. Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues.
Barbieri RL; Hornstein MD
Endocr Rev; 1999 Jun; 20(3):249-52. PubMed ID: 10368770
[No Abstract] [Full Text] [Related]
19. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
20. The empiric use of gonadotropin therapy and intrauterine insemination.
Schlaff W; Yazigi R; Olive DL; Williams DB; Steinkampf M; Odem RR
Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 2):778-82. PubMed ID: 7872381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
